Table 2.
Nucleoporin translocation partners in cancer
Nucleoporin | Partner Genes | Partner function | Diseases | Refs | |
---|---|---|---|---|---|
Tpr | Met | HGF receptor tyrosine kinase | gastric carcinoma | 42, 45, 46, 123 | |
NTrk1 | NGF receptor tyrosine kinase | papillary thyroid carcinoma | 124, 125 | ||
| |||||
Nup214 | DEK | chromatin binding/remodeling | AML, MDS | 96 | |
SET | chromatin binding/remodeling | AML, AUL, T-ALL | 95 | ||
ABL1 | receptor tyrosine kinase | T-ALL | 120 | ||
| |||||
Nup98 | HD | HoxA9, 11, 13 | transcription factor | AML, MDS, CML | 67, 68, 126, 127 |
HoxC11, 13 | transcription factor | AML, MDS | 128, 129, 132 | ||
HoxD11, 13 | transcription factor | AML, MDS, CML | 130, 131 | ||
PMX1(PRRX1) | transcription factor | AML, MDS, CML | 133 | ||
PMX2(PRRX2) | transcription factor | AML, MDS | 134 | ||
HHEX | transcription factor | AML | 76 | ||
| |||||
non-HD | DDX10 | RNA helicase | AML, MDS | 135 | |
Top1 | type I DNA topoisomerase | AML, t-MDS | 136, 137, 138 | ||
Top2B | type II DNA topoisomerase | AML | 139 | ||
LEDGF | transcriptional co-factor | AML, CML | 142 | ||
NSD1 | histone methyltransferase | AML | 143 | ||
NSD3 | histone methyltransferase | AML | 144 | ||
SETBP1 | SET binding protein | T-ALL | 149 | ||
JARIDIA | RbBP2, histone demethylase | ABL | 147 | ||
RAP1GDS1 | guanine nucleotide exchange factor | T-ALL | 140, 141 | ||
Adducin-3 | subunit of actin filament binding complex | AML | 145 | ||
ANKRD28 | ankyrin domain repeats | AML, MDS | 148 | ||
PHF23 | a hypothetical PHD finger protein | AML | 150 | ||
C6ORF80 | unknown | AML, T-ALL | 146 | ||
LOC348801 | unknown | AML | 151 | ||
IQCG | unknown | ABL | 89 |
AML: acute myleoid leukemia; MDS: myelodysplastic syndrome; CML: chronic myleoid leukemia; T-ALL: T-cell acute lymphoblastic leukemia; ABL: acute biphenotypic leukemia; t-MDS: therapy-related myelodysplastic syndrome; AUL: acute undifferentiated leukemia; NGF: nerve growth factor